Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Blinded, Randomized Study to Evaluate the Safety and Effictiveness of a Low and Standard Dose Biolimus A9TM Drug-Eluteing Coronary Stent Delivery System Compared With a TaxusTM LiberteTM Control Arm for Treatment of Stenotic Lesions in Native Coronary Arteries.

NCT01172119 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT01172119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01172119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Blinded, Randomized Study to Evaluate the Safety and Effictiveness of a Low and Standard Dose Biolimus A9TM Drug-Eluteing Coronary Stent Delivery System Compared With a TaxusTM LiberteTM Control Arm for Treatment of Stenotic Lesions in Native Coronary Arteries.
Lead sponsor
Biosensors Europe SA
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2008
Completion date
July 31, 2014
Enrollment
182 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of stenotic lesions in native coronary arteries.